MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

Search

ResMed Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

259.78 1.9

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

251.28

Max

259.96

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-31M

349M

Pardavimai

-12M

1.3B

P/E

Sektoriaus vid.

26.391

90.831

Dividendų pajamingumas

0.87

Pelno marža

26.096

Darbuotojai

10,600

EBITDA

-29M

503M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+15.44% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

0.87%

2.20%

Kitas uždarbis

2026-01-29

Kitas dividendų mokėjimo data

2026-03-19

Kita Ex Dividend data

2026-02-12

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-193M

38B

Ankstesnė atidarymo kaina

257.88

Ankstesnė uždarymo kaina

259.78

Naujienos nuotaikos

By Acuity

33%

67%

68 / 361 reitingas Healthcare

ResMed Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-01-14 22:41; UTC

Įsigijimai, susijungimai, perėmimai

Canadian Natural Resources, Tourmaline File Deal Notice With Antitrust Regulator

2026-01-15 00:00; UTC

Uždarbis

Welcome to Greenland, an Economy Reliant on Subsidies and Shrimp -- WSJ

2026-01-14 23:47; UTC

Rinkos pokalbiai

Oil Slips After Trump Appears to Tilt Away From Military Action in Iran -- Market Talk

2026-01-14 23:44; UTC

Rinkos pokalbiai

Nikkei May Decline After Hitting Record Highs; Election in Focus -- Market Talk

2026-01-14 23:39; UTC

Rinkos pokalbiai

ANZ's New Bull Still Sees Valuation Gap to Peers -- Market Talk

2026-01-14 23:32; UTC

Rinkos pokalbiai

Gold Declines on Likely Technical Correction, Possible Profit-Taking -- Market Talk

2026-01-14 22:56; UTC

Įsigijimai, susijungimai, perėmimai

Soho House Amends Rollover and Support Agreements With Broad Street Principal Investments and Others

2026-01-14 22:53; UTC

Įsigijimai, susijungimai, perėmimai

Soho House: Apollo Global Management and Goldman Sachs Asset Management Amend Debt Commitment

2026-01-14 22:17; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-01-14 22:17; UTC

Rinkos pokalbiai

WiseTech's Revenue Growth Drivers Attract Scrutiny -- Market Talk

2026-01-14 22:09; UTC

Uždarbis

CITIC Securities: Uptrend in China Capital Markets Supported Results >600030.SH

2026-01-14 22:08; UTC

Uždarbis

CITIC Securities 2025 Oper Rev CNY74.83B Vs. CNY58.12B >600030.SH

2026-01-14 22:08; UTC

Uždarbis

CITIC Securities 2025 Net CNY30.05B Vs. Net CNY21.57B >600030.SH

2026-01-14 21:53; UTC

Įsigijimai, susijungimai, perėmimai

WuXi XDC Expects 2025 Net to Increase Over 38% on Year

2026-01-14 21:53; UTC

Įsigijimai, susijungimai, perėmimai

WuXi XDC Expects 2025 Revenue to Increase More Than 45% on Year

2026-01-14 21:52; UTC

Įsigijimai, susijungimai, perėmimai

WuXi XDC Announces Positive Profit Alert for 2025

2026-01-14 21:51; UTC

Įsigijimai, susijungimai, perėmimai

Citigroup Acting as Financial Advisor to WuXi XDC

2026-01-14 21:51; UTC

Įsigijimai, susijungimai, perėmimai

WuXi XDC: Aims to Keep Listing Status of BioDlink

2026-01-14 21:51; UTC

Įsigijimai, susijungimai, perėmimai

WuXi XDC: Company to Finance BioDlink Shares Acquisition via Internal Resources

2026-01-14 21:50; UTC

Rinkos pokalbiai
Uždarbis

Financial Services Roundup: Market Talk

2026-01-14 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-01-14 21:49; UTC

Įsigijimai, susijungimai, perėmimai

WuXi XDC: BioDlink Offer to Cost HK$2.79B

2026-01-14 21:48; UTC

Įsigijimai, susijungimai, perėmimai

WuXi XDC Offers to Pay HK$4.00 for Each BioDlink International Share

2026-01-14 21:48; UTC

Įsigijimai, susijungimai, perėmimai

WuXi XDC Makes Cash Offer for BioDlink International

2026-01-14 21:13; UTC

Rinkos pokalbiai

Oil Retreats Late After Trump Comments on Iran -- Market Talk

2026-01-14 20:30; UTC

Rinkos pokalbiai
Uždarbis

Danaher's Preliminary 4Q Seen as Promising -- Market Talk

2026-01-14 20:13; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Sink Ahead of Storage Report -- Market Talk

2026-01-14 20:08; UTC

Rinkos pokalbiai

Oil Futures Extend Rally on Iran Tensions -- Market Talk

2026-01-14 19:33; UTC

Rinkos pokalbiai

Nutrien Seen as Winner in Tighter 2026 Potash Market, Higher Prices -- Market Talk

2026-01-14 19:06; UTC

Rinkos pokalbiai
Uždarbis

Wells Fargo Says Customers, Economy Remain Resilient -- Market Talk

Akcijų palyginimas

Kainos pokytis

ResMed Inc Prognozė

Kainos tikslas

By TipRanks

15.44% į viršų

12 mėnesių prognozė

Vidutinis 294 USD  15.44%

Aukščiausias 345 USD

Žemiausias 260 USD

Remiantis 11 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines ResMed Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

11 ratings

6

Pirkti

5

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

68 / 361 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat